12.68

1.93% 0.24

After Hours: 12.72 0.04 +0.32%

Benitec Biopharma Inc (BNTC)

Overview News Price History Financials Discussions Forecast Stock Split

Benitec Biopharma Inc stock is traded at $12.68, with a volume of 44,993. It is up +1.93% in the last 24 hours and up +1.28% over the past month. Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Previous Close:

$12.44

Open:

$12.33

24h Volume:

44,993

Relative Volume:

0.33

Market Cap:

$435.61M

Revenue:

$7,000

Net Income/Loss:

$-41.54M

P/E Ratio:

-13.65

EPS:

-0.929

Net Cash Flow:

$-20.57M

1W Performance:

+1.68%

1M Performance:

+1.28%

6M Performance:

+16.22%

1Y Performance:

-9.43%

1-Day Range:

$12.33

$12.83

1-Week Range:

$11.80

$13.28

52-Week Range:

$9.85

$16.76

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name

Benitec Biopharma Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(510) 780-0819

Address

3940 TRUST WAY, HAYWARD, CA

Employee

Twitter

@BenitecLtd

Next Earnings Date

2026-09-28

Latest SEC Filings

BNTC's Discussions on Twitter

Compare BNTC vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BNTC Benitec Biopharma Inc	12.68	446.95M	7,000	-41.54M	-20.57M	-0.929
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-07-25	Initiated	TD Cowen	Buy
Dec-16-24	Initiated	H.C. Wainwright	Buy
Dec-13-24	Initiated	Robert W. Baird	Outperform
Oct-16-24	Initiated	Oppenheimer	Outperform
Sep-12-24	Initiated	Guggenheim	Buy
Jul-22-24	Initiated	Leerink Partners	Outperform
Jun-13-24	Initiated	Piper Sandler	Overweight
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy
Sep-16-15	Reiterated	Maxim Group	Buy

View All

Benitec Biopharma Inc Stock (BNTC) Latest News

Sep 04, 2026

(BNTC) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Sep 04, 2026

Enterprise value to revenue forward of Benitec Biopharma Inc. – NASDAQ:BNTC - TradingView

Sep 04, 2026

Sep 02, 2026

Benitec Biopharma Inc.ADR Peer Comparison – Compare with Others - Value Research

Sep 02, 2026

Aug 20, 2026

Benitec (BNTC) Levels: Posts a 4.33% Loss to $12.80 in the Latest Session; Current Setup: Price Remains Between $12.16 Support and $13.44 Resistance at the CloseVolume Spike Alerts - vinanet.vn

Aug 20, 2026

Benitec (BNTC) Earnings Update: The EPS Result Is Above Expectation for the Current Session; Price Reaction: The Market Price Advances 3.88% in the Latest ReadingLow Growth Earnings - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Benitec (BNTC) EPS and Revenue: EPS Beats Its Estimate in Latest Trading; Latest Reaction: Shares Close 1.45% Lower on the DayPeak Earnings Alert - vinanet.vn

Aug 19, 2026

Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat

Aug 19, 2026

Aug 14, 2026

Trading Systems Reacting to (BNTC) Volatility - Stock Traders Daily

Aug 14, 2026

BNTC Q2 2026 Earnings: Loss Narrows More Than Expected as EPS Beats Estimates by 14%Profit Guidance Range - vinanet.vn

Aug 14, 2026

Aug 13, 2026

Benitec Biopharma (BNTC) Advances 3% as Shares Test Key Resistance LevelUnusual Call Volume - Vinanet

Aug 13, 2026

Aug 12, 2026

BNTC Q2 2026 Earnings: EPS Beats Estimates Despite Revenue Absence and Share DeclineEarnings Growth Analysis - vinanet.vn

Aug 12, 2026

Aug 11, 2026

Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50 Day Moving AverageTime to Sell? - marketbeat.com

Aug 11, 2026